Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 12/2015

21-06-2015

Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure—Non-severe Hypoglycemic Events (TRIM-HYPO)

Auteurs: Meryl Brod, Lise Højbjerre, Donald M. Bushnell, Charlotte Thim Hansen

Gepubliceerd in: Quality of Life Research | Uitgave 12/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Non-severe hypoglycemic events (NSHEs) are commonly experienced by diabetes patients, particularly among insulin users, and can have serious impacts on daily functioning, emotional well-being, sleep, work productivity, and treatment adherence. Currently, no PRO measures are available to assess the impacts of non-severe hypoglycemia. To address this gap, the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO) was developed. This paper describes the TRIM-HYPO development and validation.

Methods

The creation of the TRIM-HYPO followed FDA’s guideline for PRO development. Concept elicitation data were gathered from literature review, clinical expert interviews, and focus groups of patients with Type 1 or 2 diabetes in four countries. Based on the qualitative analysis, draft items were generated and cognitively debriefed. Psychometric validation included factor analysis, item response theory analysis, and assessment of psychometric characteristics for the TRIM-HYPO.

Results

Eight clinical experts and 167 patients participated in concept elicitation. The validation study included 407 patients. Thirteen of the 46 items from the preliminary measure were dropped due to ceiling/floor effects and high correlations between conceptually similar items. Factor analysis confirmed five domains in the TRIM-HYPO: daily function, emotional well-being, diabetes management, sleep disruption, and work productivity. All scores were internally consistent (0.86–0.95) and reproducible with a test–retest range of 0.75–0.98. All but one a priori hypothesized associations for validity were confirmed.

Conclusions

Study findings demonstrate that the final, 33-item TRIM-HYPO is reliable and valid and may be useful for assessing impacts related to NSHEs in research and clinical practice.
vorige artikel Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population
volgende artikel Dynamic weight-bearing assessment of pain in knee osteoarthritis: a reliability and agreement study
Literatuur
1.
Workgroup on Hypoglycemia, American Diabetes Association. (2005). Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on hypoglycemia. Diabetes Care, 28(5), 1245–1249.CrossRef
2.
Kovatchev, B., Cox, D., Farhy, L., Straume, M., Gonder-Frederick, L., & Clarke, W. (2000). Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. The Journal of Clinical Endocrinolgy and Metabolism, 85(11), 4287–4292.
3.
Brod, M., Christensen, T., Thomsen, T., & Bushnell, D. (2011). The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value in Health, 14(5), 665–671.CrossRefPubMed
4.
Davis, R., Morrissey, M., Peters, J., Wittrup-Jensen, K., Kennedy-Martin, T., & Currie, C. (2005). Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Current Medical Research and Opinion, 21(9), 1477–1483.CrossRefPubMed
5.
6.
Vexiau, P., Mavros, P., Krishnarajah, G., Lyu, R., & Yin, D. (2008). Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes, Obesity & Metabolism, 10, 16–24. doi:10.​1111/​j.​1463-1326.​2008.​00883.​x.CrossRef
7.
Unger, J. (2012). Uncovering undetected hypoglycemic events. Diabetes, Metabolic Syndrome and Obesity, 5, 57–74.
8.
Brod, M., Wolden, M., Christensen, T., & Bushnell, D. M. (2013). A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes, Obesity & Metabolism, 15(6), 546–557. doi:10.​1111/​dom.​12070.CrossRef
9.
Brod, M., Christensen, T., & Bushnell, D. M. (2012). The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes. Journal of Medical Economics, 15(5), 869–877. doi:10.​3111/​13696998.​2012.​686465.CrossRefPubMed
10.
11.
12.
Anarte Ortiz, M. T., Caballero, F. F., Ruiz de Adana, M. S., Rondán, R. M., Carreira, M., Domínguez-López, M., et al. (2011). Development of a new Fear of Hypoglycemia Scale: FH-15. Psychological Assessment, 23(2), 398–405. doi:10.​1037/​a0021927.CrossRefPubMed
13.
14.
15.
Sheehan, D. (1983). The anxiety disease. New York, NY: Charles Scribner and Sons.
16.
Dupuy, H. (1984). The psychological general well-being (PGWB) index. In N. Wenger, M. Mattson, C. Furburg, & J. Elinson (Eds.), Assessment of quality of life in clinical trials of cardiovascular therapies (pp. 170–183). New York: Le Jacq Publishing.
17.
Hays, R., & Stewart, A. (1992). Sleep Measures. In A. Stewart & J. Ware (Eds.), Measuring functioning and well-being: The medical outcomes study approach (pp. 235–259). Durham, NC: Duke University Press.
18.
Wild, D., Clayson, D., Keating, K., & Gondek, K. (2005). Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: The Activity Impairment Assessment (AIA). Health and Quality of Life Outcomes, 3, 42.PubMedCentralCrossRefPubMed
19.
Reilly, M., Zbrozek, A., & Dukes, E. (1993). The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics, 4(5), 353–365.CrossRefPubMed
20.
Anderson, R. T., Skovlund, S. E., Marrero, D., Levine, D. N., Meadows, K., Brod, M., et al. (2004). Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics, 26(4), 565–578.CrossRefPubMed
21.
Russell, D. (1996). UCLA Loneliness Scale (Version 3): Reliability, validity, and factor structure. Journal of Personality Assessment, 66(1), 20–40.CrossRefPubMed
22.
Hann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K. K., et al. (1998). Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory. Quality of Life Research, 7(4), 301–310.CrossRefPubMed
23.
Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacology Bull, 29(2), 321–326.
24.
Atkinson, M. J., Kumar, R., Cappelleri, J. C., & Hass, S. L. (2005). Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value in Health, 8(Suppl 1), S9–S24.CrossRefPubMed
25.
Aaronson, N., Alonso, J., Burnam, A., Lohr, K. N., Patrick, D. L., Perrin, E., et al. (2002). Scientific advisory committee of the medical outcomes trust: Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205.CrossRefPubMed
26.
Wright, B., & Masters, G. (1982). Rating scale analysis: Rasch measurement. Chicago, IL: MESA Press.
27.
Wright, B., & Linacre, J. (1994). Reasonable mean-square fit values. Rasch Measurement Transactions, 8, 370.
28.
Cronbach, L. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef
29.
King, P., Kong, M. F., Parkin, H., Macdonald, I. A., & Tattersall, R. B. (1998). Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care, 21(3), 341–345.CrossRefPubMed
30.
Jauch-Chara, K., Hallschmid, M., Gais, S., Schmid, S. M., Oltmanns, K. M., Colmorgen, C., et al. (2007). Hypoglycemia during sleep impairs consolidation of declarative memory in type 1 diabetic and healthy humans. Diabetes Care, 30(8), 2040–2045.CrossRefPubMed
31.
Brod, M., Wolden, M., Christensen, T., & Bushnell, D. M. (2013). Understanding the economic burden of non-severe nocturnal hypoglycemic events: Impact on work productivity, disease management, and resource utilization. Value in Health, 16(8), 1140–1149.
32.
Brod, M., Christensen, T., & Bushnell, D. M. (2012). Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function. Journal of Medical Economics, 15(1), 77–86.CrossRefPubMed
33.
Fanelli, C. G., Paramore, D. S., Hershey, T., Terkamp, C., Ovalle, F., Craft, S., et al. (1998). Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes, 47(12), 1920–1927.CrossRefPubMed
34.
Matyka, K. A., Wigg, L., Pramming, S., Stores, G., & Dunger, D. B. (1999). Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes. Archives of Disease in Childhood, 81(2), 138–142.PubMedCentralCrossRefPubMed
35.
Fulcher, G., Singer, J., Castañeda, R., Fraige Filho, F., Maffei, L., Snyman, J., et al. (2014). The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: Two international surveys. Journal of Medical Economics, 17(10), 751–761.CrossRefPubMed
36.
Geelhoed-Duijvestijn, P. H., Pedersen-Bjergaard, U., Weitgasser, R., Lahtela, J., Jensen, M. M., & Östenson, C. G. (2013). Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries. Journal of Medical Economics, 16(12), 1453–1461.CrossRefPubMed
37.
Brod, M., Pohlman, B., Wolden, M., & Christensen, T. (2013). Non-severe nocturnal hypoglycemic events: Experience and impacts on patient functioning and well-being. Quality of Life Research, 22(5), 997–1004.PubMedCentralCrossRefPubMed
38.
Brod, M., Wolden, M., Groleau, D., Bushnell, D.M. (2014). Understanding the economic, daily functioning and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2. Journal of Medical Economics, 17(1), 11–20.
39.
40.
41.
Kleinman, L., Leidy, N. K., Crawley, J., Bonomi, A., & Schoenfeld, P. (2001). A comparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) Questionnaire. Medical Care, 39(2), 181–189. doi:10.​2307/​3768040.CrossRefPubMed
42.
43.
Metagegevens
Titel
Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure—Non-severe Hypoglycemic Events (TRIM-HYPO)
Auteurs
Meryl Brod
Lise Højbjerre
Donald M. Bushnell
Charlotte Thim Hansen
Publicatiedatum
21-06-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 12/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1023-6

Andere artikelen Uitgave 12/2015

Quality of Life Research 12/2015 Naar de uitgave

OriginalPaper

How is an informal caregiver’s psychological distress associated with prolonged caregiving? Evidence from a six-wave panel survey in Japan

Brief Communication

Relationship of type of work with health-related quality of life

Brief Communication

Proposing a re-adapted successful aging model addressing chronic diseases in low- and middle-income countries

OriginalPaper

Long-term health-related quality of life of living kidney donors: a single-center experience

OriginalPaper

Examining differential responses of youth with and without autism on a measure of everyday activity performance

OriginalPaper

Clinical improvement and satisfaction after total joint replacement: a prospective 12-month evaluation on the patients’ perspective